How to Calculate TAM, SAM and SOM Without Inflating Them
A full worked market-size build from free public data: arithmetic shown, assumptions listed, and the point where my number disagrees with a paid report.
Last updated: 31 August 2026
The most upvoted thing I found researching this was a founder on r/startups: "Most market size slides are bullshit and investors know it." 357 people agreed. Someone on X put it more precisely: $500B TAM slides scream fantasy math.
That is not confusion about definitions. That is a founder who knows the slide is fake and shows it anyway, because received wisdom says you need a billion-dollar number to be fundable.
The trap. Any number you can defend from real data looks small. Any number big enough to clear the funding bar cannot be defended. Most advice picks a side and ignores the other.
The way out is not a bigger number. It is a different unit of measurement. Stop competing on the size of the circle. Compete on a property anyone can check in ten seconds: how many of your inputs open in a browser. A slide where every input opens survives the room. One with an unopenable headline does not, at any size.
Something I measured. On 24 August 2026 I logged every source six AI engines returned for this exact question. Forty-five unique domains came back. One was a government domain. Not one was a statistical agency you could count from. No Census Bureau, no Bureau of Labor Statistics, no CMS. Thirty-five of the forty-five sell software or services. The engines are full of advice about counting and empty of the things you count.
Below is a build from those missing sources, arithmetic shown, including the part where a paid report's own U.S. figure lands inside my range and the part where the global headlines disagree with each other.
Three methods exist. Top-down starts from a published industry figure and filters down. Bottom-up counts customers and multiplies by price. Value theory sizes the value your product creates, for markets that do not exist to count yet.
Pear VC surveyed 30 VCs and reported they prefer bottom-up because the assumptions can be tested, with top-down as a sanity check only. OpenVC agrees. One caveat worth holding onto: venture funds are authoritative about what investors accept, not about what is arithmetically correct.
That preference holds at seed and inverts at scale. Uber's early deck used a conservative $4.2B taxi figure. Uber's 2019 S-1 put personal mobility alone at $5.7 trillion, a figure Uber itself describes as covering markets it had yet to enter. The discipline everyone recommends belongs to people with no traction to show yet.
Worth naming, because a founder who read four guides and got four answers is not being stupid.
Wikipedia's own TAM definition holds two incompatible readings in a single sentence: a global total "even if a particular company could not reach some of it," or "more commonly, a sub-market that one specific product or service could serve." On SAM, HubSpot constrains by geography and specialisation, Salesforce by geography and demographics, HG Insights by business model, geography and ICP. None agree on whether regulation or capability sit inside SAM.
SOM is the least defended. Amazon Ads treats it as a share estimate filtered by brand awareness and budget. Pear VC's respondents preferred a bottom-up revenue build over a hypothetical percentage of TAM, and their most consistent single piece of feedback was to dissuade founders from presenting future revenue as a share of a large addressable market at all. So SOM is variously a share, a capacity estimate and a revenue plan, depending who is writing.
Define which reading you are using, on the slide. The disagreement is not your fault. The ambiguity is still your problem.
- Define the unit of demand. An establishment, a seat, or a transaction. Vista Point notes that for an enterprise software company, a per-user build can be more accurate than one based on average contract value. Choose deliberately: the unit determines the answer.
- Count it. Census County Business Patterns gives establishment counts by NAICS code and geography, annually, free to download. Bureau of Labor Statistics data reaches you through FRED. CMS publishes national health spending.
- Price it from evidence. Published vendor pricing, filings, comparable ARPU. Not aspiration.
- Filter, one assumption per step. Geography, segment, capability, willingness to pay. Elev-x puts the standard well: each step rests on a single statable assumption an investor can challenge, "and you can answer with data rather than hand-waving."
- Disclose the register. Ainna: credibility "lives or dies on assumption transparency."
- Build a range. Sources disagree on how far bottom-up and top-down may diverge before something is wrong: Ainna says three to five times, Data-Mania treats agreement within 15% as the sign your assumptions are sound. Report both and explain your gap.
Eight mechanisms produce almost every inflated slide. Each has a question that collapses it.
| Mechanism | How it looks | The question that exposes it |
|---|---|---|
| Headline broader than product | "Dental market = $500B" | Which line items in that figure do you actually sell? |
| Circular sourcing | "$X0B (multiple reports)" | What single original dataset do all these trace to? |
| Adjacent-market inclusion | "Healthcare + fintech + SaaS = $800B" | Which of these do you sell to today? |
| Price times everyone | "1B smartphone users x $10" | What share of those have the problem and will pay? |
| Forecast year shown as current | "$50B market" (silently 2030) | Is that this year, or a projection, and from when? |
| Currency or unit inconsistency | mixing currencies, or units with revenue | Are all inputs the same currency, base year and unit? |
| Value-chain double count | platform GMV shown as revenue | Is that GMV, or your take-rate revenue? |
| Segment drift | TAM "all SMBs," ICP "solo dermatologists" | Why doesn't your TAM match your ICP slide? |
Two deserve expanding. Circular sourcing: information appears to come from several independent sources but traces to one. Randall Munroe named the loop citogenesis in November 2011. I could not trace a closed press-release-to-report-to-press-release loop inside market research, so I will not claim one. The symptom is visible anyway: five publishers put the 2025 global dental software market at $1.96B, $2.36B, $2.6B, $3.1B and $3.18B, a 1.6x spread for the same market in the same year, none with an openable method.
Value-chain double count is the marketplace trap. ICanPitch reports that showing transaction volume instead of take-rate revenue inflates the number ten to twenty times.
WeWork's 2019 S-1 identified "280 target cities with an estimated potential member population of approximately 255 million people in aggregate"; multiplied by an occupancy-cost figure it produced a $3 trillion opportunity. The IPO was withdrawn within weeks.
Anyone can multiply. What an investor reads is whether your account count came from a dataset with a name and a base year, and whether your price came from a page they can open.
Two failure points sit inside those inputs. The unit: count establishments but sell seats and the number is wrong before you multiply. The base year: a 2020 count mixed with a 2030 forecast describes no year that ever existed.
For SOM, resist the reflex. A guessed 1% of a large market is the most recognisable tell in the category. Preuve.ai names it directly: "If we capture just 1% of this $50B market" is a pitch VCs "have heard 10,000 times," and "a red flag for lazy thinking." Anchor SOM to a named competitor's actual share instead, or to a revenue build from accounts you can name and reach.
Unit of demand: one U.S. dental establishment buying practice-management software.
Input 1, the count. Census Statistics of U.S. Businesses, built on County Business Patterns, NAICS 621210 "Offices of Dentists": 135,333 establishments across 122,711 firms, base year 2021. Establishments exceed firms because multi-location practices have several sites. Worth knowing which product you are quoting: County Business Patterns itself publishes establishments, not firms, and its latest year, 2023, counts 135,665 — a series that has barely moved in three years, which is itself reassuring. I use 135,000.
For a ceiling I wanted a second opinion, and the second opinion is a lesson in its own right. IBISWorld counts dental-office businesses on a different basis, and its number for calendar 2025 has been published as 180,966 and later as 177,559, with the 2024 base revised down to 175,947, no changelog attached; today the page reads 180,742 for 2026 under a renamed industry. That is one vendor's estimate of a single past year moving by roughly 3,400 businesses. It is exactly why a vendor figure needs a timestamp and a government series does not. I use 180,000 as a ceiling and date it to today.
Input 2, the price. Open Dental publishes $199 per month per location for year one and $149 after, a monthly support fee rather than a licence, so roughly $1,800 to $2,400 a year. Dentrix starts at about $500 a month; its cloud product Dentrix Ascend is reported at $500 to $800 per location per month, and Curve Dental at $300 to $500 per provider per month — neither vendor publishes a price itself. Multiplying the top of that by twelve is my arithmetic, not a published figure: call the high case $9,600. Blended: low $2,400, high $9,600, midpoint $4,800.
The arithmetic.
| Scenario | Count | Annual price | TAM |
|---|---|---|---|
| Low | 135,000 | $2,400 | $0.32B |
| Mid | 135,000 | $4,800 | $0.65B |
| High | 135,000 | $9,600 | $1.30B |
| Ceiling | 180,000 | $9,600 | $1.73B |
TAM = $0.65B, range $0.32B to $1.30B, ceiling $1.73B. Base years: count 2021, pricing 2026.
The contrast. CMS reports that spending on dental services "increased 6.6 percent in 2024 to $189.2 billion." That is what patients and insurers pay dentists, not what dentists spend on software. The honest software TAM is 0.34% of it. Citing $189B, or a $500B global dental figure, as the market for dental software is exactly the first mechanism in the table.
Where my number lands. I expected this section to be an apology. Global Market Insights puts the category at $2.6B in 2025, four times my midpoint — except that $2.6B is the global figure, and the same page puts the U.S. market at $1 billion in 2025. That lands inside my $0.32B to $1.30B range, a little above my $0.65B midpoint. The fourfold disagreement I was braced for was mostly a scope error waiting to happen: comparing a U.S. build against a global headline, which is the first mechanism in the table above, and I nearly committed it myself.
What the published figures do not do is agree with each other. For the same global market in the same year: Fortune Business Insights $1.96B, Mordor $2.36B, Global Market Insights $2.6B, Grand View $3.1B, Precedence $3.18B. None publishes an openable method. My build is reproducible and wrong in known ways; theirs may be better informed and cannot be checked. So I would show the build, note that one vendor's own U.S. figure falls inside it, and treat the global numbers as a different measurement rather than a verdict on mine.
Assumption register: 135,000 establishments, medium confidence, 2021 base year · $2,400 low price, high confidence, published by the vendor · $9,600 high price, low confidence, my own multiplication of a third-party monthly estimate · near-universal software adoption, medium confidence, assumed not measured.
It works mainly as a negative signal. Preuve.ai: a "$500B TAM" for a niche B2B tool "triggers immediate skepticism." RunwayTeam: a large number with no calculation signals a founder who copied a report. You rarely win on this slide. You routinely lose on it.
Investors also run a silent bottom-up check. Jon Warner gives the monologue: they claim a $1B TAM, "does that imply, say, 50,000 customers paying $20k each?" Your slide is reverse-engineered while you talk.
Now the contradiction nobody resolves. The method is what is graded. And the fund-math floor is real: Unicorn Screener states that "most institutional VCs need to see a TAM of at least $1 billion to justify the fund economics," with a Series A bar it puts higher still. Notice what is missing from every version of that rule: a study. WorthBuild does the same arithmetic and lands on a different threshold, $500M to $2B, which is the best evidence available that the number is a convention rather than a measurement.
Both are true at once and most advice pretends only one is. A defensible $0.65B built from Census data and vendor pricing beats an indefensible $189B, because the method is being graded. But if your defensible number cannot reach a venture-scale floor, the answer is not to inflate it. It is a wider unit of demand you can still defend, an expansion path you can evidence, or the acknowledgement that this is a good business and a poor venture fit. Three real answers. A fake number is not a fourth.
- How do I estimate TAM using bottom-up data?
- Count your demand unit from a public dataset and multiply by an evidence-based price. For U.S. dental software: roughly 135,000 establishments (Census SUSB, NAICS 621210, base year 2021) times $2,400 to $9,600 a year (Open Dental published pricing, plus a derived high case) gives $0.32B to $1.30B. Every input opens free.
- What's the difference between TAM, SAM, and SOM?
- TAM is revenue at 100% share, SAM is the slice your model, geography and product can serve, SOM is what you can realistically win near term. Sources disagree on the details, particularly on SOM. A practising VC at Beta Boom puts it plainly: there is no common standard for calculating these measures of market sizing.
- How can I avoid overestimating my market size?
- Do not cite a figure broader than what you sell, and check scope before you compare. U.S. dental services spending was $189.2 billion in 2024 (CMS), but dental software is about 0.34% of it, and a $2.6B software figure that looks four times too big turns out to be global rather than U.S. Cross-check bottom-up against top-down and disclose the gap rather than hiding it.
- What formulas are best for a startup TAM SAM SOM model?
- TAM = annual contract value times potential accounts. SAM = TAM filtered by geography, segment and capability. SOM = SAM times a share backed by a named comparable. Avoid a guessed 1% of a big market: Preuve.ai calls it a pitch VCs have heard 10,000 times and a red flag for lazy thinking. The formula is easy, the inputs are the work.
- Can you show a real TAM SAM SOM example?
- U.S. dental practice-management software. TAM: 135,000 establishments (Census SUSB 621210, 2021) times $4,800 blended annual price, about $0.65B. SAM: cloud-ready single-location practices in your region. SOM: a few percent justified by a named comparable. Contrast the inflated $189.2B CMS dental total from 2024.
Run the eight questions above against your slide, one at a time. Most fail on the first, because the headline was defined by someone selling a report, not by you.
Then rebuild one number from a source that opens. Count from Census County Business Patterns, price from a published vendor page, show the multiplication on the slide, footnote the assumptions. Every input in the dental build above is free.
If the honest number comes out smaller than you hoped, you learned it before an investor taught it to you in a room. That is the cheapest version of that lesson. It is also the version a technical founder can run alone, in an afternoon, without buying anything.
Government and filings
- Census Bureau — County Business Patterns (establishment counts; latest year 2023) and Statistics of U.S. Businesses, 2021 (establishments and firms, NAICS 621210).
- CMS — National Health Expenditures 2024 Highlights ($189.2B dental services, 2024); NHE historical hub.
- Bureau of Labor Statistics releases on FRED.
- SEC EDGAR — WeWork S-1 (2019) and Uber S-1 (2019).
Vendor pricing
- Open Dental fee page (the only vendor here that publishes its own price).
- SelectHub on Dentrix; Getmonetizely on Dentrix Ascend and Curve Dental.
Market-research estimates, none with a published method
- Global Market Insights ($2.6B global, $1B U.S., 2025) · Fortune Business Insights ($1.96B) · Mordor Intelligence ($2.36B) · Grand View Research ($3.1B) · Precedence Research ($3.18B) · IBISWorld dental-office counts (revised repeatedly; see above).
Practitioner and investor guidance
- Pear VC (survey of 30 VCs) · OpenVC · Slideworks · Beta Boom · Preuve.ai · RunwayTeam · Elev-x · Ainna · Data-Mania · ICanPitch · Vista Point Advisors · Jon Warner · Unicorn Screener · WorthBuild · HubSpot · Salesforce.
Reference
- Wikipedia — Total addressable market and Circular reporting · xkcd 978, "Citogenesis" · Blank and Dorf, The Startup Owner's Manual (2012).
My own measurement
- 24 August 2026: 40 buyer queries logged across six AI engines. On this query, 45 unique domains were cited, one government domain, zero statistical agencies, 35 selling software or services.
Related reading
- Technical Founder GTM: How Engineers Actually Sell in 2026Are technical founders bad at go-to-market, or built to win it? The honest answer turns on one variable: your buyer. A 2026 framework, evidence, and playbook.
- The Last Moat Is the One You Can't AutomateAgentic coding made building cheap, so the bottleneck moved to distribution. But trust, timing, and taste resist automation — and that's the moat.
- Is GTM Dying? No — But One Tier of It Is Being GuttedGTM isn't dying — it's bifurcating. The commodity cold-outbound tier is being gutted while the strategy and systems tier grows. Which half are you in?